HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Maccallini Selected Research

prolinamide

1/2019The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro.
5/2018Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Maccallini Research Topics

Disease

4Glioma (Gliomas)
07/2020 - 05/2018
4Neoplasms (Cancer)
07/2020 - 01/2017
4Neurodegenerative Diseases (Neurodegenerative Disease)
06/2020 - 01/2016
3Breast Neoplasms (Breast Cancer)
12/2021 - 01/2016
3Inflammation (Inflammations)
07/2021 - 06/2020
2Paraganglioma (Paragangliomas)
05/2020 - 01/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2019 - 04/2019
1Carcinogenesis
05/2022
1Triple Negative Breast Neoplasms
05/2022
1Mycoses (Diseases, Fungus)
12/2021
1Autoimmune Diseases (Autoimmune Disease)
07/2021
1Obesity
07/2019
1Hypertension (High Blood Pressure)
07/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2019
1Gallstones (Gallstone)
10/2018
1Cholestasis
10/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2017
1Cardiovascular Diseases (Cardiovascular Disease)
08/2017
1Nervous System Diseases (Neurological Disorders)
11/2016
1Metabolic Diseases (Metabolic Disease)
05/2016
1Alzheimer Disease (Alzheimer's Disease)
01/2016
1Intellectual Disability (Idiocy)
01/2016
1Cognitive Dysfunction
01/2016
1Hypotension (Low Blood Pressure)
01/2016

Drug/Important Bio-Agent (IBA)

7Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2021 - 05/2018
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019 - 05/2016
3Aromatase InhibitorsIBA
12/2021 - 01/2016
3Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2021 - 06/2020
2Biological ProductsIBA
12/2021 - 05/2018
2Aromatase (CYP19)IBA
12/2021 - 11/2021
2acetamidineIBA
06/2020 - 01/2019
2prolinamideIBA
01/2019 - 05/2018
2Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
11/2016 - 01/2016
1Histone Deacetylases (Histone Deacetylase)IBA
05/2022
1Histone Deacetylase InhibitorsIBA
05/2022
1IndazolesIBA
12/2021
1TriazolesIBA
12/2021
1Free RadicalsIBA
07/2021
1EnzymesIBA
07/2021
1compound 17IBA
07/2020
1GW 6471IBA
05/2020
1Fibric Acids (Fibrates)IBA
04/2019
1CM544IBA
01/2019
1AmidesIBA
01/2019
1benzothiazoleIBA
01/2019
1LipidsIBA
10/2018
1StilbenesIBA
01/2017
1Nitric Oxide Synthase (NO Synthase)IBA
02/2016
1Hormones (Hormone)IBA
01/2016
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1hemopressinIBA
01/2016
1Pharmaceutical PreparationsIBA
01/2016

Therapy/Procedure

7Therapeutics
05/2022 - 11/2016
2Drug Therapy (Chemotherapy)
05/2022 - 01/2019